Company Profile

SenesTech Inc (AKA: SenesTech LLC)
Profile last edited on: 8/8/2023      CAGE: 3SAK9      UEI: U6CHGRZKFYX7

Business Identifier: Humanely managing animal populations through fertility control
Year Founded
2002
First Award
2011
Latest Award
2012
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

23460 North 19th Avenue Suite 110
Phoenix, AZ 85027
   (928) 779-4143
   info@senestech.com
   www.senestech.com
Location: Single
Congr. District: 01
County: Coconino

Public Profile

SenesTech, Inc.functions as a biotech platform and research company developing and commercializing a proprietary technology for managing animal pest populations through fertility control. Whether canines, possums, rodents, or any number of other species, unregulated animal populations can create a diverse range of pressing problems across the globe. In India, for example, 60,000 children die from rabies annually, a disease transmitted by infected dogs. New Zealand's primary economic driver, the livestock industry, is threatened by the brush tail possum, vector of bovine tuberculosis. Even within the United States, uncontrolled rat populations cause destruction in urban, agricultural and industrial sectors; SenesTech’s first product had focused on proliferation of rats in both urban and agricultural settings. Readily consumed by rats, the product leaves them permanently non-reproductive with no other observable side effects: a new paradigm to the science of pest control. The firms is gearing up for the process of EPA registration, after which it will be available for commercial sale. Meanwhile, tests ranging from the New York Subway, the neighborhoods of Metropolitan Boston, and the rice fields in Southeast Asia have yielded promising results. With EPA registration completed, path to commercialization involved strategic partnerships with major manufacturer, and a leading pest control service provider actively seeking an alternative to traditional pest management methods. Early promise also offered humane control of other pest species from deer to wild pigs. Long-term, there is also potential for a SenesTech formulation to become a non-surgical solution for the spaying and neutering of feral cats and dogs.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
25-49
Revenue Range
2.5M-5M
VC funded?
No
Public/Private
Publicly Traded
Stock Info
NASDAQ : SNES
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2012 2 NIH $1,099,999
Project Title: Contrapest-An Oral Bait for Fertility Management of Rodent Pests

Key People / Management

  Cheryl A Dyer -- President

  Joel Fruendt -- President and Chief Executive Officer

  Loretta Mayer -- CEO and Chairman of the Board

  Elissa Calloway -- VP of Research

  Tom Chesterman -- Chief Financial Officer

  Suzie Martinez -- Business Manager

  Tom Ohmart -- VP Business Development

  Dan Palasky -- Chief Technical Officer